Nicocodine
- Level
- Commodity
- Parent
- 51162600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162643This classification denotes an antitussive agent with the molecular formula C24H24N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) DYX391P13E, chemically known as morphinan-6-ol, 7,8-didehydro-4,5-epoxy-3-methoxy-17-methyl-, 3-pyridinecarboxylate (ester), (5.alpha.,6.alpha.)- but more generally known as nicocodine, which bears US NIH Compound Identifier 520825. European Medicines Agency schedules Nicocodine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09233MIG. The term NICOCODINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). NICOCODINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule nicocodine under HS 29391900 and SITC 54141. As of Q4 2014, NICOCODINE remains US FDA's Preferred Term for this commodity. Nicocodine bears US NLM identifiers UMLS ID C0068697 and NCI Concept Code C84008. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)C=CC2OC(=O)C1CCCNC1.
Same parent
Under 51162600 · 55Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.